You are viewing: US Blood Glucose Monitor Market analysis
Part of: Blood Glucose Monitor Market (Global)

The US Blood Glucose Monitor Market was valued at $2502 Million in 2025 and projected to reach to $3681.7 Million by 2030, representing a compound annual growth rate of 8.0%. The US blood glucose monitor market is poised for steady growth through 2030, driven by escalating diabetes prevalence and technological advancements in glucose monitoring systems.

US Blood Glucose Monitor Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Blood Glucose Monitor Market Trends and Insights

  • This expansion reflects rising diabetes prevalence across the US population and increasing adoption of continuous glucose monitoring (CGM) technologies.
  • The US market benefits from advanced healthcare infrastructure, strong reimbursement policies, and significant investment in diabetes management solutions. Driving growth in the US market are factors including the growing prevalence of Type 2 diabetes, aging demographics, and heightened consumer awareness of preventive health monitoring.
  • Between 2025 and 2030, the US is expected to see accelerated adoption of connected and smart glucose monitoring devices.
  • The competitive landscape in the US remains robust, with both established medical device manufacturers and innovative startups competing to capture market share through technological advancement and improved patient outcomes..

Key Market Statistics

  • CAGR (2025-2030) 8.0% CAGR
  • Market Size, 2025 ~USD 2502 Million
  • Forecast, 2030 ~USD 3681.7 Million
  • Country US

US Blood Glucose Monitor Market Overview

Market Size & Growth :

The US blood glucose monitor market is valued at $2,502.0 million in 2025 and is projected to reach $3,681.7 million by 2030, growing at a CAGR of 8.0%.

Rising Diabetes Prevalence :

Increasing diabetes cases across the US population are driving demand for blood glucose monitoring devices, with both Type 1 and Type 2 diabetes patients requiring regular monitoring solutions.

CGM Technology Adoption :

Continuous glucose monitoring (CGM) technologies are experiencing rapid adoption in the US market, offering real-time glucose tracking and improved patient outcomes compared to traditional finger-stick testing.

Advanced Healthcare Infrastructure :

The US benefits from robust healthcare infrastructure, strong insurance coverage, and favorable reimbursement policies that support widespread adoption of blood glucose monitoring devices.

US Blood Glucose Monitor Market Dynamics

  • Continuous glucose monitoring devices are gaining significant traction among patients seeking improved glycemic control and convenience.
  • Healthcare providers are increasingly recommending CGM solutions, supported by favorable reimbursement policies and insurance coverage expansion. Key growth drivers include aging demographics, lifestyle-related diabetes risk factors, and growing patient awareness of proactive health management.
  • Integration of digital health platforms and smartphone connectivity is enhancing user engagement and data accessibility.
  • The competitive landscape will intensify as major medical device manufacturers invest in innovation, while emerging players introduce cost-effective alternatives, ultimately benefiting US consumers through improved product offerings and accessibility..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US blood glucose monitor market is valued at $2,502.0 million in 2025 and will reach $3,681.7 million by 2030 at an 8.0% CAGR.
    • Rising diabetes prevalence and aging demographics are primary growth drivers for the US market.
    • Continuous glucose monitoring (CGM) technology adoption is accelerating across the US healthcare system.
    • Strong reimbursement policies and advanced healthcare infrastructure support sustained market expansion in the US.

    Blood Glucose Monitor Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment NON-INVASIVE PRODUCTS (Product Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 9.1% from 2025 to 2030
    Largest Segment DIABETES MANAGEMENT (Application)
    Market Size Base Year (Billions) ~USD 16.44 (2025)
    Revenue Forecast (Billions) ~USD 25.41 (2030)
    Segments Covered Product Type, Type, Test Site, Application, End User

    US Blood Glucose Monitor Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product Type

    • Continuous Glucose Monitoring Systems
    • Non-Invasive Products
    • Professional Point-Of-Care Devices
    • Self-Monitoring Blood Glucose Systems

    By Type

    • Glucometers
    • Implants
    • Lancets & Lancing Devices
    • Sensors
    • Testing Strips
    • Transmitters & Receivers
    • Type 1 Diabetes
    • Type 2 Diabetes

    By Test Site

    • Fingertip
    • Other Test Sites
    • Upper Arm

    By Application

    • Diabetes Management
    • Health & Wellness Monitoring
    • Other Applications

    By End User

    • Hospitals & Clinics
    • Other End Users
    • Self/Home Care

    US: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    HOSPITALS & CLINICS633.9658.6688.7712.1752.5790831.1876.14.9
    OTHER END USERS379.5405.7436.5464.3504.8545.3590.2640.18
    SELF/HOME CARE4151.94500.94910.75297.15839.96396.870217721.79.5
    TOTAL5165.35565.260366473.57097.27732.28442.39237.98.9

    Target Audience

    • Medical Device Manufacturers : US-based and international manufacturers need detailed market sizing, growth forecasts, and competitive analysis to develop go-to-market strategies and optimize product portfolios for the American market.
    • Healthcare Investors & PE Firms : Investment professionals require accurate US market valuations, CAGR projections, and growth drivers to evaluate acquisition targets, fund allocation decisions, and portfolio company performance benchmarking.
    • Pharmaceutical & Diagnostic Companies : Companies seeking to expand into glucose monitoring need US-specific market intelligence, reimbursement data, and adoption trends to inform product development and commercialization strategies.
    • Healthcare Providers & Hospital Systems : US hospitals, clinics, and healthcare networks require market insights to make informed procurement decisions, evaluate technology investments, and optimize patient care delivery for diabetes management.
    • Market Consultants & Analysts : Research firms and business consultants need comprehensive US market data to support client advisory services, competitive benchmarking, and strategic planning across the healthcare technology sector.

    Key Companies in the US Blood Glucose Monitor Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyLong-term acute care hospitals (LTACHs) – drug-intensive episodes,Inpatient rehabilitation facilities (IRFs) – rehab with chronic comorbidities,Contract rehabilitation and ancillary services,
    ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices,Diagnostic Products,Nutritional Products,
    DEXCOM, INC.United StatesPublic CompanyDexcom G7 and G7 15 Day,Dexcom G6,Dexcom ONE and ONE+,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
    SINOCAREChinaPublic CompanyBlood glucose monitoring systems and strips,Blood pressure and multiparameter testing devices,Hospital and primary healthcare diagnostic solutions,
    I-SENS, INC.South KoreaPublic CompanyBlood glucose meters and strips (human),POCT systems (blood gas, electrolytes, coagulation),Veterinary diagnostics,
    NIPROJapanPublic CompanyDialysis products and services,Injection and infusion / hospital disposables,Pharmaceuticals (generics and kits),
    NEMAURA MEDICAL INC.United StatesPublic CompanysugarBEAT non-invasive CGM,proBEAT wellness and coaching programs,Diabetes prevention and reversal services,
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a private healthcare company founded in 1985 and headquartered in the United States. With 64,200 employees, the company operates as a major provider of healthcare services across the nation.

    ABBOTT LABORATORIES

    Abbott Laboratories is a public company founded in 1888 and based in the United States. With 115,000 employees, it operates as a diversified healthcare and diagnostics company with a global presence.

    DEXCOM, INC.

    Dexcom, Inc. is a publicly traded company founded in 1999 and headquartered in the United States. The company employs 11,050 people and specializes in continuous glucose monitoring technology.

    MEDTRONIC

    Medtronic is a public company founded in 1949 and based in Ireland. With 95,000 employees, it is a global leader in medical technology and device manufacturing.

    SINOCARE

    Sinocare is a publicly traded company founded in 2002 and headquartered in China. The company employs 5,010 people and operates in the healthcare and medical device sector.

    I-SENS, INC.

    I-SENS, Inc. is a publicly traded company founded in 2000 and based in South Korea. The company employs 887 people and operates in the medical device and diagnostics industry.

    NIPRO

    Nipro is a publicly traded company founded in 1947 and based in Japan. With 38,593 employees, it manufactures medical devices and pharmaceutical products for global markets.

    NEMAURA MEDICAL INC.

    Nemaura Medical Inc. is a publicly traded company founded in 2009 and headquartered in the United States. With 36 employees, the company develops wearable medical technology solutions.

    TERUMO CORPORATION

    Terumo Corporation is a publicly traded company founded in 1921 and based in Japan. With 30,591 employees, it manufactures and distributes medical devices and blood products globally.

    Reasons to Buy this Report

    • Market Size & Revenue Projections : Access precise valuation data for the US market ($2,502M in 2025) with detailed 5-year forecasts to 2030, enabling accurate financial planning and investment decisions for US-focused business strategies.
    • Growth Opportunity Analysis : Understand the 8% CAGR trajectory specific to the US market, identifying expansion opportunities driven by rising diabetes prevalence and CGM technology adoption across American demographics.
    • Competitive Landscape Intelligence : Gain insights into the US competitive environment, market dynamics, and positioning strategies of major players operating in the American blood glucose monitoring sector.
    • Regulatory & Reimbursement Insights : Understand US-specific regulatory frameworks, FDA approval pathways, insurance coverage policies, and reimbursement trends that directly impact market accessibility and profitability.
    • Strategic Market Segmentation : Identify high-growth segments within the US market including CGM vs. traditional monitors, patient demographics, geographic hotspots, and distribution channels for targeted market entry.

    Frequently asked questions

    What is the current size of the US blood glucose monitor market?

    The US blood glucose monitor market is valued at $2,502.0 million in 2025.

    What is the projected size of the US blood glucose monitor market by 2030?

    The US blood glucose monitor market is projected to reach $3,681.7 million by 2030.

    What is the CAGR for the US blood glucose monitor market?

    The US blood glucose monitor market is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2030.

    What are the main drivers of growth in the US blood glucose monitor market?

    Key growth drivers in the US include rising diabetes prevalence, aging demographics, increased adoption of continuous glucose monitoring technology, and strong healthcare reimbursement policies.

    Which technologies are gaining traction in the US blood glucose monitor market?

    Continuous glucose monitoring (CGM) devices and connected smart glucose monitoring solutions are experiencing accelerated adoption across the US market.

    RESEARCH METHODOLOGY

    The study comprised four key activities to estimate the current size of the blood glucose monitor market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step involved validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Top-down and bottom-up approaches were used to arrive at a comprehensive estimate of the overall market size. Finally, market breakdown and data triangulation techniques were utilized to determine the sizes of segments and subsegments within the market.

    Secondary Research

    The secondary research process involved extensive use of various secondary sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the blood glucose monitor market. It also helped obtain critical insights about key players in the industry, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.

    Primary Research

    In the primary research process, interviews were conducted with various sources from the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts were interviewed, including CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from prominent companies and organizations involved in the blood glucose monitor market. For the demand side, interviews were conducted with industry experts, purchase and sales managers, doctors, and personnel from research organizations. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the blood glucose monitor market is provided below:

    Blood Glucose Monitor Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the blood glucose monitor market includes the following details. The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the blood glucose monitor market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall blood glucose monitor market was obtained from secondary data and validated by primary participants to arrive at the total blood glucose monitor market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region and Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall blood glucose monitor market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Blood Glucose Monitor Market Size: Bottom-up Approach and Top-down Approach

    Blood Glucose Monitor Market

    Data Triangulation

    After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

    Market Definition

    Blood glucose monitors are medical devices used to measure and monitor blood glucose (sugar) levels in individuals, primarily for the diagnosis and management of diabetes mellitus. These monitors help patients and healthcare professionals assess glycemic control, adjust treatment plans, and prevent diabetes-related complications.

    Stakeholders

    • Blood Glucose Monitor Manufacturers
    • Contract Manufacturers
    • Suppliers and Distributors of Blood Glucose Monitors
    • Senior Management
    • Finance Department
    • Healthcare Services Providers (Hospitals and Public & Private Clinics)
    • Academic & Research Institutes
    • E-commerce and Digital Platforms
    • Retail Pharmacies and Supermarkets
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, analyze, and forecast the global blood glucose monitor market by product type, application, test site, end user, and region.
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the blood glucose monitor market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
    • To profile the key players in the blood glucose monitor market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product approvals & launches in the blood glucose monitor market.

    Get the Full Blood Glucose Monitor Market Report

    Full forecast, segment splits, and company analysis for all Blood Glucose Monitor Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status